ISCO Stock UPDATES Intl Stem Cell Corp (ISCO) 0.0950 09/02/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Intl Stem Cell Corp (ISCO) 0.0950 $ISCO

International Stem Cell Corporation to Present at Two Upcoming Investment Conferences
Marketwire - Thu Aug 28, 7:30AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, today announced that Executive Vice President Dr. Simon Craw will present a corporate overview of ISCO and its subsidiaries at two upcoming investment conferences.

International Stem Cell Corporation Provides R&D and Business Results for Second Quarter and First Half of 2014
Marketwire - Tue Aug 12, 7:32AM CDT
International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical products today provided a business update and announced financial results for the three and six months ended June 30, 2014.

International Stem Cell Corporation to Host Second Quarter 2014 Business Update and Financial Results Conference Call at 11:00 am ET on Tuesday, August 12, 2014
Marketwire - Thu Aug 07, 7:32AM CDT
International Stem Cell Corporation (OTCQB: ISCO) a California-based biotechnology company developing novel stem cell based therapies and biomedical products announced today that it will host a conference call on Tuesday, August 12, 2014 to provide a business update and discuss its financial results for the three and six months ended June 30, 2014.

International Stem Cell Corporation Launches Stroke Program With Tulane University
Marketwire - Tue Aug 05, 7:33AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company" , a California-based biotechnology company developing novel stem cell based therapies, announced today that it has launched a new Stroke Program. Together with Tulane University, ISCO will study the impact of human parthenogenetic neural stem cells (hpNSC) transplantation in a pre-clinical rodent model of ischemic stroke as a first step toward the clinical development of a potential stroke treatment. The proof-of-concept study will be done in the laboratory of Dr. Jean-Pyo Lee, a well-known expert in the field of regenerative medicine.

International Stem Cell Corporation Secures Approval for Core Technology Patents in European Union
Marketwire - Tue Jul 22, 7:32AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company" , a California-based biotechnology company developing novel stem cell based therapies and biomedical products, received formal opinion from the Advocate General for the European Union Court of Justice (CJEU) in favor of the Company's pending core technology patents.

Lifeline Cell Technology Expands Asian Distribution Network
Marketwire - Wed Jul 16, 7:30AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company" , a California-based biotechnology company focused on therapeutic and research products, today announced that its subsidiary, Lifeline Cell Technology, has expanded its sales network by adding a number of new distributors in Asia and Oceania.

International Stem Cell Corporation Signs Agreement Including Certain Terms for a Definitive License Agreement With Rohto Pharmaceutical Co., Ltd. of Japan
Marketwire - Tue Jul 08, 7:30AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com, ISCO or the Company), a California-based biotechnology company developing novel stem cell-based therapies, announced today that it has entered into a research agreement with Rohto Pharmaceutical Co., Ltd. ("Rohto" , a global Japanese pharmaceutical company that develops new technology for the medical and cosmetics markets with approximately $1.3 billion in consolidated annual sales. Under this agreement, Rohto will evaluate stem cell-derived human cells owned and provided by ISCO in a number of pre-clinical animal models. If the research is successful and the parties agree on remaining terms, it is anticipated that a definitive license agreement will be signed at the end of the twelve-month period of this research agreement. Certain key terms of such a license agreement, including the target disease areas and intellectual property rights, have been established in the research agreement.

International Stem Cell Corporation Completes Important Study in Parkinson's Disease Program
Marketwire - Thu Jun 19, 7:30AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company" , a California-based biotechnology company developing novel stem cell based therapies, announced today the completion of the acute toxicity study of the Company's proposed clinical product to treat Parkinson's disease. The recently completed IND-enabling study transplanting rodents with human neural stem cells, derived from ISCO's proprietary parthenogenetic stem cell platform, showed that the cells are well tolerated even at high doses up to the equivalent of 2.2 billion cells in humans. The program continues to progress according to the plan outlined with the FDA at the pre-IND meeting as reported in February 2014. The Company intends to provide a further update early next quarter.

International Stem Cell Corporation to Present at BIO 2014
Marketwire - Tue Jun 17, 2:24PM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, today announced that Executive Vice President Dr. Simon Craw, will present an overview of ISCO and its subsidiaries at the BIO 2014 conference on Tuesday, June 24th at 4:15 pm PDT. The conference is being held at the San Diego Convention Center.

Lifeline Skin Care Expands Into Latin America's Second Largest Market
Marketwire - Tue Apr 01, 7:30AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com), a California-based biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that Lifeline Skin Care, its operating subsidiary, has signed a distribution agreement with Grupo Venta Internacional, S.A de C. V., Mexico's largest distributor of aesthetic and reconstructive products. Effective immediately, Grupo Venta Internacional will offer Lifeline's breakthrough stem cell skin care products to health care professionals throughout Mexico, the second largest market for aesthetic skin care in Central and South America.

International Stem Cell Corporation Announces 2013 Fourth Quarter and Year-End Results
Marketwire - Tue Mar 18, 7:31AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company" , a California-based biotechnology company developing novel stem cell-based therapies and biomedical products, today provided a business update and announced fourth quarter and year-end financial results for the year ended December 31, 2013.

International Stem Cell Corporation to Host Full-Year 2013 Business Update and Financial Results Conference Call Wednesday, March 19, 2014
Marketwire - Thu Mar 13, 7:31AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com), a California-based biotechnology company developing novel stem cell-based therapies and biomedical products announced today that management will host a conference call on Wednesday, March 19, 2014 to provide a business update and discuss its financial results for the year ended December 31, 2013.

Odemwingie Pleased With Stoke Debut
All Africa Global Media - Tue Feb 04, 4:56AM CST
Out of favour Super Eagles forward, Osaze Peter Odemwingie has spoken of his delight following his Barclays English Premier League debut for Stoke City last weekend. Odemwingie completed an 18-month move to the Britannia Stadium on January 28 and was immediately thrown into the deep end by the Stoke Manager, Mark Hughes, against Manchester United on Saturday.

International Stem Cell Corporation Advances Parkinson's Disease Program Towards IND Stage
Marketwire - Mon Sep 09, 7:30AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com), a California-based biotechnology company developing novel stem cell-based therapies, announced today further progress in its Parkinson's disease program with a recently held key opinion leader meeting facilitated by the study's principal investigator, Dr. Mark Stacy of Duke Medicine.

International Stem Cell Corporation to Present at Rodman & Renshaw 15th Annual Global Investment Conference September 8th to 10th
Marketwire - Wed Aug 28, 7:30AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today that it will participate in Rodman & Renshaw's 15th Annual Global Investment Conference sponsored by H.C. Wainwright & Co., LLC. The conference is being held September 8-10, 2013, at the Millennium Broadway Hotel in New York City.

International Stem Cell Corporation Enters Into Clinical Research Agreement for Parkinson's Disease Program
Marketwire - Wed Aug 21, 7:30AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) a California-based biotechnology company developing novel stem cell-based therapies, announced today that it has entered into a master clinical research agreement with Duke University to conduct clinical trials research in Parkinson's disease using ISCO's innovative neural stem cell product.

International Stem Cell Corporation Announces Second Quarter 2013 Financial Results
Marketwire - Thu Aug 08, 7:30AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company" , a California-based biotechnology company developing novel stem cell based therapies and biomedical products, today announced financial results for the three and six months ended June 30, 2013.

Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on International Stem Cell Corporation
Marketwire - Tue Aug 06, 7:30AM CDT
Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO) on International Stem Cell Corporation (OTCQB: ISCO). The full 72-page report is available on Crystal Research Associates' website at www.crystalra.com.

International Stem Cell Corporation to Host Second Quarter 2013 Financial Results Conference Call at 11:00 a.m. ET on Friday, August 9, 2013
Marketwire - Thu Aug 01, 4:00PM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) a California-based biotechnology company developing novel stem cell based therapies and biomedical products announced today that it will host a conference call on Friday, August 9, 2013 to discuss its financial results for the three and six months ended June 30, 2013.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Memorial Manor's Five-Star Signal in Long-Term Care

Updated Category News Views 130

Care quality is the only score that matters here A nursing home recognition is not the sort of news anybody should read like a trophy-case press release and then forget by lunch. Families make decisions around long-term care when they are tired, worried, and often dealing with a parent or spouse whose needs have changed fast. In that setting, a facility putting up both a...

Continue Reading
Thoughts Unleashed Arrives With a Personal American Voice

Updated Category News Views 114

A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...

Continue Reading
AMPERA Joins Berto to Power Future Energy Innovations

Updated Category News Views 163

The Power Play You Didn't See Coming AMPERA and Berto just made a move that could stir up some serious waves in the energy sector. They've inked a business combination deal set to push advanced energy technology to the forefront. With AMPERA's valuation clocking in at roughly $900 million, this partnership aims to bring cutting-edge power solutions from concept to market....

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 186

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading
Benicia's Bold Move to Streamline Permitting Pays Off

Updated Category News Views 147

Award-Winning Innovation from Benicia Benicia, California, shoots ahead of the pack by scooping up a highly coveted Helen Putnam Award for Excellence. Why? They chopped down bureaucracy like a lumberjack with a new ax by ushering in a digital revolution for their permitting process. Make no mistake, folks, this ain’t just a pat on the back—it's a blueprint for cities...

Continue Reading
Unishippers Climbs 18 Slots on 32.4% Sales Growth Run

Updated Category News Views 127

Thirty new franchise units can move the needle fast Unishippers did not inch its way up the Franchise Times Top 400; it put up a number that deserves a hard look. Sales rose 32.4% in 2025, the company added 30 franchise units, and the result was an 18-place jump to No. 81 on the 2026 ranking. In the shipping category, it was named the sales-growth leader. For a business...

Continue Reading
New Flight Charters Puts a Cap on Winter Surprises

Updated Category News Views 151

Ice on a wing is routine; ice on an invoice is where charter customers start muttering. New Flight Charters says it will again absorb de-icing and hangar charges this winter, up to $2,500 per trip, marking the seventh consecutive season for the program. In a business where the headline quote can look tidy and the final bill can arrive wearing muddy boots, that is a...

Continue Reading
Legato Frames Put Tiny AI to a Real-World Hearing Test

Updated Category News Views 142

A hearing aid that never enters the ear is a deceptively brutal product challenge. It has to hear speech through a mess of restaurant clatter, traffic, wind and ordinary human commotion; it has to run all day; and, crucially, it cannot look like a medical concession somebody reluctantly straps on. Legato Frames are aiming right at that knot, with femtoAI providing the...

Continue Reading
Suntory Flowers Tests NASCAR as a Garden Retail Engine

Updated Category News Views 24

Orange sheet metal and flowering vines are an odd couple, which is precisely why this South Florida promotion has some bite. A plant marketer took a hard left turn Suntory Flowers put its Sun Parasol mandevillas alongside DGM Racing at Homestead-Miami Speedway, celebrating the millions of plants grown in South Florida. That is not a conventional horticulture play, and...

Continue Reading
SanMar’s Lott Tops Promo Products Power 50 Again in 2026

Updated Category News Views 102

Branded hoodies and logo tumblers rarely make Wall Street’s pulse race, but the numbers behind them deserve a hard look. Jeremy Lott, president and CEO of SanMar, was named the most influential leader in the U.S. promotional-products business for the second consecutive year, taking No. 1 in the 2026 Counselor Power 50 ranking. Awards can be fluff. A repeat win beside...

Continue Reading

Top 5 Most Recently Viewed Articles

GroupBy and adCAPTCHA: A New Era for eCommerce Security

Updated Category News Views 110

Strengthening eCommerce with Cutting-Edge Technology GroupBy Inc., a pioneering SaaS provider in eCommerce search and product discovery, recently announced a vital partnership with adCAPTCHA, a state-of-the-art security verification platform. This collaboration focuses on enhancing digital customer experiences while ensuring robust security measures are in place. The...

Continue Reading
Frost & Sullivan Boosts China Insight with LeadLeo

Updated Category News Views 90

Navigating China's Complex Market Landscape You've got to understand, the stakes in China are like a high-wire act—mystifying and risky, yet bountiful if you play your cards right. Frost & Sullivan's latest maneuver into China's business intel scene is basically the lifeline for navigating this increasingly convoluted market. With China surging ahead in AI, biotech, and...

Continue Reading
Important Update for MoonLake Immunotherapeutics Investors

Updated Category News Views 171

Update for MoonLake Immunotherapeutics Investors Investors in MoonLake Immunotherapeutics, known by its stock symbol MLTX, should pay attention to an important class action development that impacts their rights. It is crucial for individuals who purchased common stock during a designated time frame to understand their options and the benefits of securing legal...

Continue Reading
Upcoming Changes to the Issuing and Paying Agent at WisdomTree

Updated Category News Views 228

WisdomTree Multi Asset Issuer Public Limited Company, based in Ireland, made waves back in 2024 when it decided to switch up its Issuing and Paying Agent as part of an overhaul to improve its operations. Apex IFS Limited had been holding that title, but as the filing revealed, WisdomTree was ready for a change—a transition to Apex Fund Services (Ireland) Limited was on...

Continue Reading
Foxconn India Strengthens Manufacturing with Key Equipment Buy

Updated Category News Views 156

Foxconn India Makes a Strategic Equipment Acquisition Foxconn, a subsidiary of Hon Hai Precision Industry Co., Ltd., has made significant strides in enhancing its manufacturing capabilities in India. The company has successfully completed a notable acquisition of essential electromechanical equipment from CINDA ENGINEERING AND CONSTRUCTION PRIVATE LIMITED. This strategic...

Continue Reading